This topic contains a solution. Click here to go to the answer

Author Question: A perfectly competitive industry always has a perfectly elastic (flat) long-run supply curve. a. ... (Read 608 times)

naturalchemist

  • Hero Member
  • *****
  • Posts: 542
A perfectly competitive industry always has a perfectly elastic (flat) long-run supply curve.
 a. True
  b. False
  Indicate whether the statement is true or false

Question 2

If the marginal utility of each good consumers buy does not diminish but remains constant, we should witness consumers:
 a. buying no goods at all.
  b. spending all of their income on the good with the highest MU.
  c. buying one of each good.
  d. buying only the least expensive goods.
  e. become indifferent to what goods they buy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chem1s3

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

False

Answer to Question 2

b





 

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library